Atlas Trials

A Study of Autologous Induced Islet Body With Type 1 Diabetes

Clinical trial NCT03728296 · UNKNOWN

Trial details

NCT number
NCT03728296
Sponsor
Allife Medical Science and Technology Co., Ltd.
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2019-01-01
Primary completion
2020-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.